BenevolentAI
internal validation pipeline generated from the benevolent platform | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
November 2022
Slide
11 of 17
Similar slides by BenevolentAI
See diffirences between slides (animation)
Results
March 2023
robust pipeline entirely generated by the benevolent platform highlights all pipeline programmes generated using the benevolent platform ben phase read out ben novel target with zero prior linkage to delivered drug candidate within years from initiation starting phase year target collaboration expanded in to include systemic lupus heart failure | BenevolentAI
Investor Conference
January 2023
robust pipeline entirely generated by the benevolent platform | BenevolentAI
Investor Conference
January 2023
robust pipeline entirely generated by the benevolent platform | BenevolentAI
Investor Presentation
October 2022
internal validation pipeline generated from the benevolent platform | BenevolentAI
Related slides by other companies
AstraZeneca
Results
April 2023
rare disease highlights pioneering in rare neurology to improve patient outcomes registry complete terminal complement inhibition patients on low dose after year potential best in class weekly self | AstraZeneca
Nuvalent
Investor Presentation
February 2024
clinical development strategy for ongoing phase supports goal of moving up the treatment paradigm naive and treated ongoing global open label cohort phase with registrational intent enrollment planned across north and all patients receive at primary objective by blinded independent central review secondary objectives additional efficacy measures dor intracranial activity overall safety and tolerability confirmation of profile pros phase opportunity approval in both and cohort tumor type treatment status prior prior i positive naive none a positive treated any positive solid tumor any prior therapy none any registrational intent explorator cohort without | Nuvalent
Exscientia
Results
March 2024
elucidate phase ongoing in advanced solid | Exscientia
Exscientia
Investor Presentation
July 2023
elucidate phase ongoing in advanced solid | Exscientia
Other recent decks by BenevolentAI
See all presentations (11 decks)
Investor Presentation
September 2024
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights